Frontlight ResearchEarly access
Peripheral artery disease trials in Netherlands
7 of 9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in NetherlandsReducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
- Where
- Eindhoven, Nijmegen
- Age
- 18 years and over
- People
- 7,050 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07318610 · EU 2025-522954-37-00 - Phase 3Taking peopleEfficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- Where
- Dordrecht, Eindhoven, HB Nijmegen
- Age
- 18 years and over
- People
- 1,205 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07223593 · EU 2025-523283-21-00 - Phase 3Taking peopleLow Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Where
- Amersfoort, Delft, Deventer, Doetinchem, Gouda, Groningen, Harderwijk, Leiderdorp, Maastricht, 'S-Hertogenbosch, Tilburg, Utrecht
- Age
- 18 years and over
- People
- 6,150 worldwide
- Run by
- Population Health Research Institute
See details and how to joinNCT04774159 · EU 2024-512091-35-01 - Phase 2/3Taking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Apeldoorn, Eindhoven, Rotterdam
- Age
- 18 years and over
- People
- 3,110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - No phaseTaking peopleThe GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
- Where
- Arnhem, Tilburg
- Age
- 18 years and over
- People
- 244 worldwide
- Run by
- W.L.Gore & Associates
See details and how to joinNCT05811364 - No phaseTaking peopleSELUTION4BTK Trial
- Where
- Nieuwegein
- Age
- 18 years and over
- People
- 376 worldwide
- Run by
- M.A. Med Alliance S.A.
See details and how to joinNCT05055297 - Phase 1Taking peopleSafety, tolerability, and biodistribution of [89Zr]Zr-DFO-APAC (Phase 0) in subjects with peripheral arterial occlusive disease / critical limb ischemia (PAOD/CLI) and healthy volunteers – an open label PET study (CHASE-study)
- Where
- Groningen
- Age
- 18 years and over
- People
- 10
- Run by
- Aplagon Oy
See details and how to join2023-505287-11-01